Journal of Rheumatic Diseases

Table. 2.

DMARDs at the time of cancer diagnosis in rheumatoid arthritis patient

DMARDs prescription patterns Total
(n=40)
Surgery only
(n=21)
Chemotherapy
(n=19)*
csDMARDs (n=31)
Monotherapy (n=4) MTX 3 3 0
SSZ 1 1 0
Combination (n=27) MTX (+) 22 8 14
MTX (–) 5 2 3
Biologics (n=9) MTX (+) 5 4 1
MTX (–) 4 3 1

DMARDs: disease modifying anti-rheumatic drugs, csDMARDs: conventional synthetic DMARDs, MTX: methotrexate, SSZ: sulfasalazine, MTX (+): methotrexate used, MTX (–): methotrexate not used. *Chemotherapy only=nine, Adjuvant chemotherapy=ten.

J Rheum Dis 2022;29:162~170 https://doi.org/10.4078/jrd.2022.29.3.162
© J Rheum Dis